EZH2 promotes a bi-lineage identity in basal-like breast cancer cells

R. Z. Granit, Y. Gabai, T. Hadar, Y. Karamansha, L. Liberman, I. Waldhorn, I. Gat-Viks, A. Regev, B. Maly, M. Darash-Yahana, T. Peretz, I. Ben-Porath*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


The mechanisms regulating breast cancer differentiation state are poorly understood. Of particular interest are molecular regulators controlling the highly aggressive and poorly differentiated traits of basal-like breast carcinomas. Here we show that the Polycomb factor EZH2 maintains the differentiation state of basal-like breast cancer cells, and promotes the expression of progenitor-associated and basal-lineage genes. Specifically, EZH2 regulates the composition of basal-like breast cancer cell populations by promoting a 'bi-lineage' differentiation state, in which cells co-express basal- and luminal-lineage markers. We show that human basal-like breast cancers contain a subpopulation of bi-lineage cells, and that EZH2-deficient cells give rise to tumors with a decreased proportion of such cells. Bi-lineage cells express genes that are active in normal luminal progenitors, and possess increased colony-formation capacity, consistent with a primitive differentiation state. We found that GATA3, a driver of luminal differentiation, performs a function opposite to EZH2, acting to suppress bi-lineage identity and luminal-progenitor gene expression. GATA3 levels increase upon EZH2 silencing, mediating a decrease in bi-lineage cell numbers. Our findings reveal a novel role for EZH2 in controlling basal-like breast cancer differentiation state and intra-tumoral cell composition.

Original languageAmerican English
Pages (from-to)3886-3895
Number of pages10
Issue number33
StatePublished - 15 Aug 2013

Bibliographical note

Funding Information:
We thank Eli Pikarsky, Yuval Dor and Yehudit Bergman for critical reviewing of the manuscript, Marius Wernig for the Fip-EZH2 construct, Alex Roesch and Meenhard Herlyn for the pLU-JARID1Bp-GFP-BlastR construct and Sabine Werner for the CK14 promoter plasmid. We thank Norma E. Kidess–Bassir for histological support. This study was supported by the Israel Science Foundation (Grant 1560/07), the Israel Cancer Association, the Israel Cancer Research Foundation, and the Joint Research Fund IMRIC-Hadassah.


  • EZH2
  • GATA3
  • Polycomb
  • basal-like
  • breast cancer
  • differentiation


Dive into the research topics of 'EZH2 promotes a bi-lineage identity in basal-like breast cancer cells'. Together they form a unique fingerprint.

Cite this